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Deglycosylation of Tropheryma 
whipplei biofilm and discrepancies 
between diagnostic results during 
Whipple’s disease progression
Gilles Audoly, Florence Fenollar, Jean-Christophe Lagier, Hubert Lepidi & Didier Raoult
Whipple’s disease is a systemic infectious disease associated with the bacterium Tropheryma whipplei. 
Numerous reports have presented puzzling discrepancies between diagnosis methods. We addressed 
this confusion using fluorescent in situ hybridization and immunofluorescence assays to evaluate 
34 duodenal biopsies and 1 lymph node biopsy from Whipple’s patients. We showed the presence 
of bacteria in both CK20+ epithelial cells and CD68+ macrophages. Bacteria are found embedded in 
a biofilm hindering the detection of T. whipplei. Only after treatment of biopsies by glycosidases, 
co-localization of T. whipplei RNA/DNA with bacterial proteins was restored. Moreover, using 13 
bronchoalveolar lavages and 7 duodenal biopsies, we found that hydrolysis of the biofilm weakened the 
bacteria, facilitated bacterial DNA extraction and improved the sensitivity of qPCR detection by up to 
1000x opening new perspectives for diagnostic and scientific approaches.
Whipple’s disease (WD) is a systemic disease that predominantly affects the intestine and is associated with the 
presence of Tropheryma whipplei in macrophages1,2. The diagnosis of this disease is often carried out by a duoden-
oscopy with histological examination, including periodic acid-Schiff (PAS) staining in conjunction with PCR and 
immunochemistry. Histological studies of mucosal biopsy sections using standard PAS staining have detected 
massive infiltration of the lamina propria by foamy macrophages, a finding that has long been considered the 
pathognomonic hallmark of WD3.
Since the first description of a genetic procedure for the diagnosis of WD4, the culturing of T. whipplei and 
the sequencing of its genome5–7 have allowed for the development of specific molecular biology techniques, 
including PCR-based diagnosis. Furthermore, axenic culture of T. whipplei8 enabled isolation of multiple T. whip-
plei strains from many clinical samples9. This technique also allowed for the development of specific antibodies 
to uncover the presence of the bacteria in paraffin-embedded tissue sections or circulating macrophages10,11. 
Immunohistochemistry using mouse or rabbit polyclonal antibodies is a useful complement for PAS staining, as 
it may avoid false positive results found by PAS12. However, these diagnostic methods have demonstrated their 
limitations in opposing situations13,14. First, there are cases where healthy T. whipplei carriers have a positive 
PCR-based diagnosis from saliva, feces, and duodenal biopsy samples15,16. Conversely, when a WD patient begins 
antibiotherapy, PCR detection becomes negative soon after treatment. This result is the opposite of the slow clear-
ance of bacterial DNA observed during treatment of infective endocarditis17. In contrast, discontinuing treatment 
for WD is associated quickly with relapse and a positive PCR-based diagnosis18. Moreover, in duodenal biopsies 
PCR detection is negative, while PAS staining and T. whipplei-specific immunohistochemistry are positive for 
months or years after the start of treatment19,20.
Scanning electron microscopy studies revealed a biofilm corresponding to an assemblage of surface-associated 
microbial cells that is enclosed in an extracellular polymeric substance to form their immediate environment. 
This matrix is thought to be responsible for the different staining characteristics of the intracellular versus extra-
cellular forms of T. whipplei, as well as the surprising bacterial resistance against chemical treatment21. The biofilm 
might also play a role in the survival of virulent strains in the intra/extracellular compartment of the host. It is 
well established that bacteria within a biofilm are known to adopt a distinct physiological state, as well as employ 
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Figure 1. Detection and localization of T. whipplei in duodenal biopsy sections. (a,b) The sections of 
patients presenting Whipple disease (WD) or (c) an uninfected patient control without WD (W/O WD) were 
imaged using a confocal microscope, with the green channel (Alexa488) showing hybridizations of 16S rRNA 
probes Tw-617 and Tw-1402 and the red channel (Alexa550) showing immunostaining of CD68; The nuclei 
are counterstained with DAPI in blue. The white-boxed area of upper right image is magnified in the four 
images of panel (b) showing the merge image and the individual emission channels for each fluorophore. T. 
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specific attachment and detachment mechanisms, that could have profound implications for the clinical manifes-
tations such as inflammation, antibiotics resistance, persistence or the spread of the infectious agents22.
The precise nature of the biofilm surrounding the T. whipplei is currently unknown, but the corresponding 
gene cluster involved in extracellular polysaccharide synthesis5,6, as well as Wisp genes coding for a 110-kD sur-
face hyper-glycosylated protein, was associated with the formation of this biofilm23. The composition of the bio-
film is likely involved in fooling the immune system because the lower immunological response in WD patients 
is mostly restricted to proteins associated with glycans24, while asymptomatic carriers and patients with chronic 
disease have a strong antibody response against bacterial antigens25.
Bacterial biofilms found in clinical samples contain complex polysaccharides, which retain components 
known to inhibit PCR-based diagnostics and provide mechanical/chemical resistance26–28. These factors led us 
to test the hypothesis that the biofilm surrounding T. whipplei hindered detection of this bacterium by molec-
ular probes and antibodies. We investigated the role of bacteria-embedding glycans in macrophage vacuoles 
using different diagnostic methods. We tested the effects of glycosidase treatment on an in vitro-cultivated strain 
of T. whipplei and clinical samples from WD patients using fluorescent in situ hybridization (FISH), confocal 
analysis and PCR. The discrepancies between the different diagnostic methods were eliminated by simple treat-
ment with glycosidases, which also resulted in improved assay sensitivity. Our results provided insight into the 
phenomenon leading to the discrepancy between these detection methods and improved diagnostic interpreta-
tion. Additionally, this work mainly focused on Whipple bacillus detection in duodenal biopsies, expanding our 
understanding of the pathogenesis of WD and the early stages of WD.
Detection and localization of T. whipplei in paraffin embedded biopsies from patients 
with Whipple’s Disease
We first conducted a series of FISH assays on 38 duodenal biopsies (DB), including 34 from WD patients undergo-
ing therapy and 3 from unrelated patients. For FISH analysis, we used two different probes, Tw-617 and Tw-1402, 
which are complementary to regions within the T. whipplei 16S rRNA and match species-specific sequences. The 
confocal microscopy analysis of T. whipplei-specific probes bound to DB from the 34 WD patients, revealing that 
the bacteria were concentrated in relatively few cells and presented as positively DAPI-stained structures around 
the DAPI-stained nuclei (Fig. 1a,b, Supplementary Figures 1, 2). DB specimens with classical villous organization 
from 3 control patients without WD did not bind to T. whipplei-specific probes (Fig. 1c). We also used the previ-
ously described T. whipplei probes Tw-652 (Supplementary Figure 1), which complement a T. whipplei-specific 
region of 16S rRNA, and the universal Eub 338 probe, which targets most of the eubacteria (Supplementary 
Figure 2). These probes detected similar cell populations as those previously detected with Tw-617 and Tw-1402, 
confirming the presence of T. whipplei in our samples. From 18 biopsies, confocal microscopy established that the 
T. whipplei 16S rRNA probes co-localized with the T. whipplei wisp gene DNA probes (Supplementary Figure 1). 
Most of the signals of the DNA wisp genes matched with the 16S rRNA probes, suggesting that this portion of the 
bacteria are transcriptionally active and presumably targets viable bacteria, while a minor fraction of the bacteria 
detected only with wisp gene probes are dead or with an undetectable transcriptional activity (Supplementary 
Figure 1).
Furthermore, our confocal analyses revealed that FISH signals surrounded nuclei (Supplementary Figure 3) 
and co-localized with IF staining of CD68+ vacuoles (Fig. 1a,b). In merge images, the signals indicated morphol-
ogy typical of infected macrophages with the accumulation of bacteria inside the CD68+ compartments (Fig. 1, 
Supplementary Figures 1, 2, 3).
Moreover, bacterial FISH probes revealed bacteria in the cytoplasm of some CD68 negative cells, located in 
the villi with a pyramidal morphology (Fig. 1, Supplementary Figure 4). Using the differentiation marker of the 
intestinal epithelium, cytokeratin 20 (CK20) and 16S rRNA probes we evidenced a productively infection in rare 
epithelial cells. The bacteria are concentrated in CK20 rich regions (Fig. 2, Supplementary Figure 4) or diffused 
in the cytoplasm of epithelial cells (Fig. 1b, Supplementary Figure 4). Few evidences of extracellular bacteria were 
found in our samples from WD patients undergoing therapy. No signal was detectable using the non-specific 
nonEub probe on samples from Whipple patients (Supplementary Figure 2). Taken together, these results demon-
strated that both CD68+ compartment of macrophages and cytoplasm of CK20+ epithelial cells support the 
replicative form of the pathogen.
Moreover, a lymph node from a patient (A19) with Whipple’s disease (Supplementary table 8), prior an anti-
biotherapy, presenting a positive PCR to whi2 gene in blood specimen was tested using FISH as previously done 
for duodenal biopsies. The sections of the lymph node bound 16S rRNA probes Tw-617 and Tw-1402, revealed 
long rope-like structures. At higher magnification, the bacteria are localized in areas sharing staining with the 
cytoplasmic F-actin surrounding cells (Fig. 3). The negative-control probe nonEub did not hybridize the lymph 
node sections. A lymph node from patient without Whipple’s disease did not bind 16S rRNA probes Tw-617 and 
Tw-1402. This approach allowed us to obtain a qualitative image of bacterial T. whipplei distribution in the lymph 
node.
whipplei are detected in CD68+ compartment of macrophages. Some CD68− cells, evocating epithelial cells, 
were also infected and present a diffuse cytoplasmic FISH signals showing free individual bacteria. FISH probes 
are concentrated in CD68+ vacuoles appear in yellow/white color surrounding nucleus, note that most of the 
bacterial DNA present in CD68+ vacuoles are stained by DAPI suggesting a high concentration of bacteria 
in phagosomes. No bacteria were detected in uninfected patient control without WD (W/O WD). Scale 
bars = 10 μm or indicated in the image.
www.nature.com/scientificreports/
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Figure 2. Confocal microscopy visualization of intracellular T. whipplei in epithelial cells of duodenal 
biopsy. Fluorescent in situ hybridizations of 16S rRNA probes Tw-617 and Tw-1402 and immunofluorescence 
of CK20 were done on duodenal sections of patients presenting Whipple disease (WD) or an uninfected patient 
control without WD (W/O WD). The images correspond to merged signals for RNA probes in green, associated 
with immunostaining for CK20 in red. Nuclei are counterstained with DAPI in blue. T. whipplei are detected 
in CK20+ epithelial cell at the tip of the villus and appeared concentrated in a punctuate CK20 rich region. The 
inset region of upper left image is magnified and presented in the bottom, showing individual emission channels 
for each fluorophore. FISH probes are concentrated in CK20+ regions appear in white color due to overlap areas 
labeled with DAPI. Scale bars = 10 μm.
www.nature.com/scientificreports/
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Discrepancies between conventional immunofluorescence and fluorescent in situ hybridization 
for the detection of T. whipplei. We next addressed the spatial association between bacterial rRNA and 
T. whipplei antigens by confocal microscopy. A FISH assay performed on 18 duodenal samples from patients 
presenting WD was followed by IF using a specific serum directed against T. whipplei. The IF revealed large 
positive regions in villi, lamina propria and deeper mucosal layers in the 18 biopsies, in contrast to the 16S rRNA 
probes, which mainly bound to discrete regions and was limited to only a few positive cells (Supplementary 
Figure 5). Higher magnification of the merge images of slides from Whipple’s patients demonstrated that many 
cells detected using T. whipplei-specific FISH probes were distinct from those detected with the T. whipplei anti-
bodies (Fig. 4a). The majority of T. whipplei-specific IF staining failed to surround a nucleus stained with DAPI 
and FISH probes and may correspond to the ghost of dead, infected cells or extracellular T. whipplei antigens 
(Fig. 4a). Comparable discrepancies have been previously observed for FISH assays and PAS-reactive materi-
als29. We hypothesized that these discrepancies were linked to the presence of a protective T. whipplei biofilm in 
infected cells that masked bacterial detection.
Surface oligosaccharides of T. whipplei biofilm impairs detection by FISH/IF assays. We first 
evaluated the effect of different pretreatment protocols with detergents and/or protease to improve the bacteria 
detection in T. whipplei-infected MRC5 cells by unmasking target antigens and 16S rRNA. Neither pretreatment 
with SDS, triton x -100, or NP40, either alone or in combination with protease, nor elevated temperature, led to 
increased co-localization of FISH and IF signals relative to our previous results, only few intracellular bacteria 
Figure 3. Confocal microscopy detection of T. whipplei in lymph node of patient presenting Whipple 
disease. Fluorescent in situ hybridizations of 16S rRNA probes Tw-617 and Tw-1402 in green channel, the 
F-actin staining in red were done on sections of patients presenting Whipple disease (WD) or an uninfected 
patient control without WD (W/O WD). The images correspond to merged signals for RNA probes in green, 
associated with phallacidin staining in red. Nuclei are counterstained with DAPI in blue. Scale bars are indicated 
on each image.
www.nature.com/scientificreports/
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are both revealed by FISH and IF. In contrast, pretreatment consisting of the hydrolysis of N- and O-link glycans 
allowed co-detection of most of bacteria in infected cells by 16S rRNA probes and antibodies (Supplementary 
Figure 6). Interestingly, by comparing the relative fluorophore signal intensity with background autofluorescence 
and exposure time, we found that the FISH signals following glycosidase treatment detected bacteria with a 
stronger staining than in untreated cells. The reactivity of antibodies to unglycosylated bacterial antigens was 
slightly lower in treated cells but remained sufficient to detect individual bacteria.
Based on this result, we further investigated the effect of N- and O-glycosidase activity on 18 tissue slides 
from patients with Whipple’s disease and 2 slides from patients without Whipple’s disease. Confocal micros-
copy analysis of all of the 18 WD biopsies was positive for FISH signal. The removal of carbohydrates improved 
detection by DNA/RNA-specific probes of infected cells (Fig. 4b). Most of infected cells showed that the DNA/
RNA-specific probes co-localized with T. whipplei specific IF, corresponding to bacteria associated with vacuoles 
(Fig. 4b, Supplementary Figure 5). Some IF-positive regions within mucosa did not bound FISH probes, enlight-
ening that the mucosa contains glycosylated, extracellular T. whipplei antigens (Supplementary Figure 5).
We used software to quantify the co-localization of signals from confocal images with parameters which sig-
nificantly reduce the pseudo-colocalization and ensure the reliability of calculations. As shown in Fig. 5, the 
Figure 4. Deglycosylation restores an identical spatial distribution of T. whipplei FISH signals in positive 
area detected with specific IF of duodenal sections of patients presenting Whipple disease (WD). Confocal 
microscopy images illustrate the FISH 16S rRNA probes in green and the red IF staining by T. whipplei-specific 
antibodies in untreated samples with glycosidases (a) and samples treated with glycosidases (b). The co-
localizations of FISH and IF signals were poorly observed in the untreated samples. In contrast, images from 
samples treated with glycosidases revealed the FISH in green overlapped with red IF staining by T. whipplei-
specific antibodies leading to white signals indicating co-localization with DAPI staining. The regions of 
duodenal biopsy only stained by specific antibodies correspond to bacteria with degraded RNA or secreted T. 
whipplei antigens. These images are representative of observations for each condition. Bar scale are indicated in 
each image.
www.nature.com/scientificreports/
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Pearson’s coefficient from samples treated with glycosidases ranged from 0.55 to 0.95, corresponding to moderate 
to very strong correlation. Furthermore, the mean of the overall coefficients indicated strong co-localization 
(mean = 0.76 +/− 0.134). In contrast, the corresponding coefficient values from untreated samples were lower, 
ranging from moderate to weak co-localization (mean = 0.44 +/− 0.189) with 13/18 slides below 0.5. Only one 
sample showed a coefficient similar to that of a treated sample (0.89 vs 0.90). Overall, glycosidase treatment 
markedly improved co-localization of signal in macrophages, demonstrating that the glycan biofilm embedded 
the replicative form of T. whipplei and hindered bacterial detection.
N- and O-glycans protect T. whipplei bacteria from lysis. We hypothesized that surface glyco- 
conjugates have a protective role for T. whipplei and should therefore be removed to allow for efficient bacterial 
lysis and subsequent detection by qPCR. We assumed that processing would be sufficient to promote lysis of the 
bacteria during the denaturation step of qPCR. We used a pool of T. whipplei, E. coli, and an aliquot of purified 
human DNA to serve as reference calibration in real-time quantitative PCR (qPCR); One-third was treated with 
a glycosidase cocktail, the second-third with lysozyme, the last received no treatment. As shown in Fig. 4, the 
detection of T. whipplei through qPCR of the whi2 gene improved upon pretreatment with a glycosidase cocktail 
relative to untreated controls (mean of Ct: 13.23 ± 0.93 vs 20.46 ± 0.13). However, treatment with lysozyme did 
not significantly alter the detection of T. whipplei (18.75 ± 0.50 vs 20.46 ± 0.13). Detection of E. coli using qPCR 
amplification of OmpG was more effective following lysozyme treatment (Ct: 12.80 ± 0.26 vs 19.60 ± 0.23), and 
moderately changed after treatment with glycosidase (Ct: 17.66 ± 0.26 vs 19.6 ± 0.23). The variation in the rela-
tive number of T. whipplei target sequences (= 2−ΔΔCT) after glycan removal demonstrated enhanced sensitivity 
of whi2 qPCR by 274-fold. Amplification of the control target, human β -actin, was nearly identical between 
glycosidase-treated samples (mean: 27.73 ± 0.37), lysozyme-treated samples (28.60 ± 0.26) and untreated sam-
ples (26.99 ± 0.03), indicating good inter-assay reproducibility. For each input, we observed no significant differ-
ences between each of the three individual qPCR reactions (less than 0.5 cycles, P < 0.01), a result that validated 
our assay.
Secondly, we wondered whether glycosidase treatment of the pooled T. whipplei and E.coli would facilitate 
extraction of bacterial DNA. The same enzymatic treatments as those described above were performed prior to 
DNA extraction of the pooled samples. Species-specific qPCR amplification was then performed in triplicate 
to monitor and quantify the detection of T. whipplei, E.coli and human DNA. Compared to untreated samples, 
we found that T. whipplei detection was more efficient after glycosidase treatment (14.32 ± 0.11 vs 18.03 ± 0.37) 
but unchanged after lysozyme treatment (18.87 ± 0.23 vs 18.03 ± 0.37). E. coli detection improved following 
lysozyme treatment (11.64 ± 0.38 vs 15.89 ± 0.12), but treatment with the glycosidase cocktail had a minimal 
effect (14.86 ± 0.29 vs 15.89 ± 0.12). The level of detection of the β -actin calibration control was equivalent for 
each test (no treatment: 27.69 ± 0.50; glycosidases: 27.48 ± 0.06; lysozyme: 28.02 ± 0.17), validating our assays 
(P < 0.01). As previously shown with direct qPCR, the removal of glycans facilitated the lysis of T. whipplei and 
extraction of its DNA, consequently increasing its detection by more than one log (Fig. 6). Overall, this demon-
strated that T. whipplei is normally embedded in a complex glycan structure to protect it from lysis.
Figure 5. Quantification of co-localization of FISH and IF signals in 18 duodenal biopsies of WD patients 
after treatment with or without glycosidases. All samples were analyzed by fluorescence confocal microscopy, 
and each image was processed to determine the Pearson’s coefficient, which ranges from 0 (no co-localization) 
to 1 (perfect co-localization). To exclude random co-localization of pixels, the image thresholds for each 
fluorophore were automatically generated using the Coste’s system. Columns present data from confocal 
analysis of each patient (A1 to A18); for each patient, columns indicate the Pearson’s coefficient for the treated 
(light grey) and untreated (dark grey) samples.
www.nature.com/scientificreports/
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Glycosidase treatment of clinical samples unmask cryptic T. whipplei DNA. We investigated the 
effect of N- and O-glycan removal on the detection of T. whipplei from DB from Whipple’s patients already tested 
in our laboratory by conventional methods, with 5 presenting a positive PAS staining and a qPCR above the 
detection threshold (> 34Ct) and 1 presenting both PAS staining and PCR positive (Tpos < 34Ct) and 1 from an 
uninfected individual (control Tneg). DNA extraction was performed on all untreated and glycosidase-treated 
samples, and triplicate T. whipplei qPCR reactions were carried out in parallel with qPCR of the β -actin gene, 
Figure 6. Effects of enzymatic treatment on RT-qPCR quantification of DNA. The graph represents the Ct-
values obtained for RT-qPCR amplification of T. whipplei whi2, and the mammalian β -actin gene on untreated 
and treated samples as indicated in the right panel. Treatments were performed either directly analysed by RT-
qPCR or after a DNA extraction as noted in the X-axis. (Significant differences between Ct-values of treated and 
untreated samples were indicated *P < 0.01).
Figure 7. Glycosidase treatment of clinical samples unmasked the embedded T. whipplei and improved 
bacterial detection using qPCR assay. Extraction of total DNA from 5 DB (a) and 13 BAL (b) samples was 
carried out after glycosidase hydrolysis in parallel of the corresponding untreated samples. Each bar represents 
the fold-change in the relative abundances of whi2 sequences of T. whipplei of each sample normalized to the 
reference β -actin gene using the 2−ΔΔCt method. All clinical information about patients (DB1 to DB5 and C1 
to C13) are listed in Supplementary information S8. Samples from asymptomatic carrier patient C13 as well 
as a sample from a duodenal biopsy (DB Tpos) from patient presenting a persistent intestine WD were used as 
positive controls. A DB Sample from a patient without histological involvement and previously controlled in a 
qPCR assay showing no amplification of T. whipplei over 40 cycles was used as no template control (Tneg).
www.nature.com/scientificreports/
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which served as an internal control for cell load. The concentration of the target whi2 gene in each sample relative 
to that of the reference actin gene (= 2−ΔΔCt) corresponds to the relative fold change quantification of bacteria 
for each condition. The removal of glycans increased the detection of T. whipplei sequences for the sample pre-
senting a PAS positive and qPCR positive result (Tpos). Of the 5 samples presenting a previously positive PAS 
staining and a qPCR > 34Ct, the detection threshold of bacteria was improved for 3 samples and below of 34 Ct 
(DB1 = 21x; DB3 = 181x; DB4 = 7x) and 2 samples were left above the detection threshold of 34 Ct (DB2; DB5).
The low variation in detection of the β -actin gene in triplicate samples validated our experimental data, which 
strongly indicate that treatment with glycosidases before DNA extraction reduces the threshold of detection in 
4 samples (Fig. 7). Taken together, these results suggest that the previous discrepancies for the detection of T. 
whipplei between a positive immunohistochemistry staining and a qPCR > 34 Ct are outcome of inhibited proper 
extraction and/or detection of nucleic acid, due to biofilm in macrophages and not a complete eradication of the 
bacteria in the patient.
As previously, we investigated bacterial load based on DNA extraction performed on untreated and 
glycosidase-treated bronchoalveolar lavage (BAL) samples from 13 patients presenting with respiratory infec-
tion. We quantified the bacterial load by qPCR as described above for the DB. Figure 7 displays the effect of gly-
can hydrolysis on the detection. Despite the low level of human DNA in all the samples, bacterial detection was 
substantially improved in 2 out of 13 clinical samples (C7 = 1350x and C13 = 275x), while in 6 others, detection 
improved by between 7.5x and 1.5x . For the remaining 5 samples, bacterial detection was essentially unchanged. 
The bacterial detection from a previously diagnosed asymptomatic carrier increased by 275x . Interestingly, our 
method allowed us to detect T. whipplei DNA from one sample from patient presenting with pneumonia. We 
found minimal variation in detection of the β -actin gene across each set of triplicate reactions, validating our 
experimental data that strongly indicated treatment with glycosidases before DNA extraction reduced the thresh-
old of detection in 7 out of 13 samples (Fig. 7).
Discussion
We found that the biofilm surrounding T. whipplei within macrophage vacuoles is composed of complex poly-
saccharides that prevent detection of the bacterial DNA in many clinical samples. The hydrolysis of the biofilm 
by glycosidases improved access to specific T. whipplei probes and allowed for detection of bacteria. The large 
regions in samples with PAS-positive staining but no signal from DNA/RNA FISH probes represented secreted 
glycosylated T. whipplei antigens or dead bacteria, rather than live T. whipplei. This result established the presence 
of remnant bacilli in intercellular spaces, a result consistent with electron microscopy on ultrathin sections of 
intestinal biopsies from WD patients, which suggested autolytic activity of T. whipplei30. Our results also support 
previous work demonstrating a difference in Gimenez staining between the T. whipplei localized within mac-
rophages and extracellular space, which was attributed to the enzymatic degradation of bacterial matrix21. On the 
other hand, our results revealing masked T. whipplei embedded inside infected cells from patients starting therapy 
and patients undergoing long-term therapy, suggest that the glycan biofilm confers a high level of resistance to 
antibiotic treatment, and supports the establishment of chronic and persistent infections. Reported cases of WD 
relapses occurring after long-term antibiotherapy support this hypothesis, albeit we cannot exclude the possi-
bility of a re-infection as chronic asymptomatic carriers of T. whipplei can be colonized by different T. whipplei 
strains over time31. The resistance to antibiotic therapy has been intimately associated with biofilm formation32,33 
and plays important roles in the chronic nature of the subsequent infections. Our model is that the excretion of 
T. whipplei which was previously identified in worsening WD29, is interrupted during the initiation of antibiotic 
treatment. Subsequently, only persistent bacteria reemerge from the intramacrophage biofilm compartment.
Here, we showed that the T. whipplei biofilm inside macrophage phagosomes confers protection and stability 
to mechanical, detergent, enzymatic and temperature stresses. These properties of surface-associated biofilms 
have previously been reported for numerous other bacteria, fungi, algae and archaea22,26,32. We propose that in 
Whipple’s disease, because of the intracellular replication niche, the concept of “compartment-associated” more 
appropriately fits this biofilm than does “surface-associated.”
Here, we were able to observe the presence of T. whipplei in the epithelial CK20+ cells. The bacterial RNA 
were found either with a diffuse staining in cytosol or with a granular pattern in CK20+ cells. The evidences of the 
presence of bacteria in few epithelial cells suggested a transcytosis of T. whipplei across epithelial layer. Then the 
clustered CD68+ macrophages around the infected epithelial cells are poised for the phagocytosis of T. whipplei. 
As T. whipplei survives by altering the phagosomal environment34, the macrophages surveillance led thereby to 
spread the infection. Aggregations of subepithelial macrophages containing bacterial RNA and DNA in numer-
ous phagosomes support this hypothesis.
The deglycosylation process of the duodenal biopsies enhanced the colocalization of FISH and IF signals. 
Nevertheless, as we observed the IF staining fades after deglycosylation of biopsies. The difference probably 
resulted from a weaker IF staining of unglycosylated and deglycosylated proteins associated with a more diffuse 
DAPI staining. The efficacy of DAPI staining was partially reduced because of the denaturation step preceding 
the enzymatic deglycosylation reactions, generating single-stranded DNA which forms much weaker fluorescent 
complexes than with double-strand DNA. Altogether, sustained FISH signals emerged significantly by comparing 
the signal following glycosidase treatment to the signal of untreated samples. We propose that FISH should be 
carried out in parallel with the histological examination as an alternative approaches required for the evaluation 
of Whipple’s disease diagnostic and useful to follow up patient care.
Our study highlighted the presence of T. whipplei using qPCR in samples of patients without other evidence 
of Whipple’s disease. The presence of low bacterial loads in numerous samples from healthy patients was already 
mentioned35,36. The deglycosylation process before qPCR detection should be useful to study the prevalence in 
healthy population.
www.nature.com/scientificreports/
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The development of original strategies to prevent and/or treat WD will likely advance significantly following 
elucidation of the nature of the biofilm in the pathogenesis of this systemic disease. The susceptibility of T. whip-
plei biofilms to glycosidases may have wider implications, as it is possible that inhibitors of PCR in tissues from 
leprosy patients could be similar to those described here27,28. Biofilms contains problematic physical inhibitors of 
the nucleic acid detection. We suggest that for live, biofilm-embedded bacteria, a simple step of glycan hydrolysis 
can be performed prior to nucleic acid extraction without significantly increasing the complexity of the extraction 
process.
Materials and Methods
Patients. This study was approved by the local ethics committee of IFR 48 (Marseille, France; n°07–035). The 
methods were carried out in accordance with the approved guidelines. Written informed consent was obtained 
from each patient for the use of information and data in the present study.
Tropheryma Whipplei strains and culture. The T. whipplei Twist strain cultured both in MRC5 fibroblast 
cells37 and in axenic medium8 were tested in this study.
Deglycosylation. Enzyme treatment to remove N- and O-linked carbohydrates from glycoproteins was per-
formed as previously described23 with modifications (see supplement information).
Fluorescent In situ hybridization assays and Confocal Microscopy. were performed as previously 
described38 with the modifications in supplement information.
Co-localization analysis. We selected FISH images and their corresponding IF images for 18 biopsies. The 
co-localization of FISH and IF signals was identified and quantified using the free JACoP software39 and detailed 
in supplement information.
Statistical analysis. The significance level throughout the study was set at P value < 0.01 using standard 
statistical software for analyses.
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